Clinical Trial Update: Naltrexone Treatment for Prolonged Grief Disorder (PGD) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating naltrexone for Prolonged Grief Disorder was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prolonged Grief Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prolonged Grief Disorder | Phase 4 | Status: TERMINATED | Results posted: 2024-08-28